Outbound Investment

Major European Private Equity Firm
Chinese Acquisition of a European Chemicals Company

KAI advised a European-based private equity firm on the sale of a chemicals company to a major state-owned Chinese chemical conglomerate, in a deal in excess of $600 million.

KAI advised on the advantages and risks of divestiture of the portfolio company, identified potential Chinese buyers based on ownership structure, government relations, and access to capital, worked with key financial and governmental institutions, managed negotiations with the Chinese buyer, and facilitated the final 100% acquisition.